Biancheri et al. demonstrated that Mmp12 contributes to the responsiveness of patients with IBD to anti-TNF agents [44] and might be involved in the remodeling of injured gut tissue with respect to the migration, proliferation, and differentiation of endothelial cells [45]. Here, TNF is linked to irritable bowel syndrome.